PipeBio

Acquired

PipeBio is a SaaS bioinformatics platform to develop antibody drugs.

Aarhus, Denmark · Founded 2020 · $316K raised

Headquarters
Aarhus
Employees
1–10
Founded
2020
Total Funding
$316K
Last Round
$316K SeedJan 2021
Rounds
1

About

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

Summary

PipeBio is a Drug Discovery company based in Aarhus, Denmark, founded in 2020. It has raised $316K in total across 1 round, most recently a $316K Seed round in Jan 2021. Investors include Y Combinator Continuity Fund, Acequia Capital and byFounders.

Tech & App Stack

6 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJan 2021
$316K

Investors

Similar Companies